基于螯合控制的生物活性构象稳定化的类药物蛋白质相互作用稳定剂的设计
Design Of Drug-Like Protein-Protein Interaction Stabilizers Guided By Chelation-Controlled Bioactive Conformation Stabilization
摘要:
14-3-3蛋白的蛋白质相互作用(PPI)是研究PPI稳定性的模型系统。复杂的天然产物Fusicoccin A稳定了许多14-3-3 PPI,但不适合用于SAR研究,这促使人们寻找更多的药物样化学物质。然而,使这种研究成为可能的药物样14-3-3 PPI稳定剂仍然难以捉摸。PPI与极低效力稳定剂复合的X射线晶体结构揭示了一种意想不到的非蛋白质相互作用的配体螯合Mg 2+,导致发现金属离子依赖性14-3-3 PPI稳定效力。这源于一种新的螯合控制的生物活性构象稳定效应。金属螯合作用与泛测定干扰化合物(PAINS)和频繁的击球行为有关,但螯合作用显然也可以导致真正的效力增加,并可用作指导化合物优化的药物化学策略。为了证明这一点,我们利用这一效应设计了第一个有效的、选择性的和药物样的14-3-3 PPI稳定剂。
英文摘要:
The protein-protein interactions (PPIs) of 14-3-3 proteins are a model system for studying PPI stabilization. The complex natural product Fusicoccin A stabilizes many 14-3-3 PPIs but is not amenable for use in SAR studies, motivating the search for more drug-like chemical matter. However, drug-like 14-3-3 PPI stabilizers enabling such study have remained elusive. An X-ray crystal structure of a PPI in complex with an extremely low potency stabilizer uncovered an unexpected non-protein interacting, ligand-chelated Mg 2+ leading to the discovery of metal ion-dependent 14-3-3 PPI stabilization potency. This originates from a novel chelation-controlled bioactive conformation stabilization effect. Metal chelation has been associated with pan-assay interference compounds (PAINS) and frequent hitter behavior, but chelation can evidently also lead to true potency gains and find use as a medicinal chemistry strategy to guide compound optimization. To demonstrate this, we exploited the effect to design the first potent, selective and drug-like 14-3-3 PPI stabilizers.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。